135 related articles for article (PubMed ID: 18537688)
1. Recent advances in liver X receptor biology and chemistry.
Goodwin BJ; Zuercher WJ; Collins JL
Curr Top Med Chem; 2008; 8(9):781-91. PubMed ID: 18537688
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic opportunities for liver X receptor modulators.
Collins JL
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
[TBL] [Abstract][Full Text] [Related]
3. Biological role of liver X receptors.
Baranowski M
J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
[TBL] [Abstract][Full Text] [Related]
4. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
[TBL] [Abstract][Full Text] [Related]
5. Liver x receptors: potential novel targets in cardiovascular diseases.
Bruemmer D; Law RE
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):533-40. PubMed ID: 16503873
[TBL] [Abstract][Full Text] [Related]
6. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
Nomiyama T; Bruemmer D
Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
[TBL] [Abstract][Full Text] [Related]
8. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential.
Gong H; Xie W
Expert Opin Ther Targets; 2004 Feb; 8(1):49-54. PubMed ID: 14996618
[TBL] [Abstract][Full Text] [Related]
9. The nuclear receptor LXR is a glucose sensor.
Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of LXR.
Michael LF; Schkeryantz JM; Burris TP
Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of liver X receptor alpha and beta is differentially regulated.
Prüfer K; Boudreaux J
J Cell Biochem; 2007 Jan; 100(1):69-85. PubMed ID: 16888799
[TBL] [Abstract][Full Text] [Related]
12. The liver X receptors.
Lala DS
Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the AF-2 region abolish ligand-induced intranuclear immobilization of the liver X receptor alpha.
Prüfer K; Hernandez C; Gilbreath M
Exp Cell Res; 2008 Aug; 314(14):2652-60. PubMed ID: 18599038
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Fiévet C; Staels B
Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
[TBL] [Abstract][Full Text] [Related]
16. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.
Smoak K; Madenspacher J; Jeyaseelan S; Williams B; Dixon D; Poch KR; Nick JA; Worthen GS; Fessler MB
J Immunol; 2008 Mar; 180(5):3305-12. PubMed ID: 18292555
[TBL] [Abstract][Full Text] [Related]
17. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.
Morales JR; Ballesteros I; Deniz JM; Hurtado O; Vivancos J; Nombela F; Lizasoain I; Castrillo A; Moro MA
Circulation; 2008 Sep; 118(14):1450-9. PubMed ID: 18794391
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors as integrators of metabolic and inflammatory signaling.
Zelcer N; Tontonoz P
J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.
Jamroz-Wiśniewska A; Wójcicka G; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():760-85. PubMed ID: 18063919
[TBL] [Abstract][Full Text] [Related]
20. Modulation of liver X receptor signaling as novel therapy for prostate cancer.
Chuu CP; Kokontis JM; Hiipakka RA; Liao S
J Biomed Sci; 2007 Sep; 14(5):543-53. PubMed ID: 17372849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]